Radiopharm Theranostics Limited (RADX)
NASDAQ: RADX · Real-Time Price · USD
4.680
-0.130 (-2.70%)
At close: Apr 1, 2025, 4:00 PM
4.930
+0.250 (5.34%)
After-hours: Apr 1, 2025, 6:31 PM EDT

Radiopharm Theranostics Cash Flow Statement

Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Dec '24 Jun '24 Jun '23 Jun '22 Jun '21
Net Income
-43-47.95-34.61-30.42-1.16
Depreciation & Amortization
4.643.133.32.98-
Loss (Gain) From Sale of Assets
1.691.69---
Asset Writedown & Restructuring Costs
1.481.483.1--
Stock-Based Compensation
2.642.643.044.80.86
Other Operating Activities
-7.928.993.8110.480
Change in Accounts Receivable
3.483.48-4.28-0.05-0.02
Change in Accounts Payable
3.53.52.352.530.24
Change in Other Net Operating Assets
0.070.070.1-0.23-
Operating Cash Flow
-33.42-22.98-23.2-9.91-0.08
Capital Expenditures
---0.05-0-
Sale (Purchase) of Intangibles
3--1.49-28.34-
Investment in Securities
----0.04-
Investing Cash Flow
3--1.53-28.38-
Short-Term Debt Issued
---0.01-
Long-Term Debt Issued
-7.37---
Total Debt Issued
4.47.37-0.010.14
Short-Term Debt Repaid
----0.07-
Long-Term Debt Repaid
--5.17---
Total Debt Repaid
-4.1-5.17--0.07-
Net Debt Issued (Repaid)
0.32.2--0.060.14
Issuance of Common Stock
73.3729.6510.07700
Other Financing Activities
-9.17-1.97-0.85-4.83-
Financing Cash Flow
64.5129.889.2265.110.14
Foreign Exchange Rate Adjustments
0.46-0.030.230.13-
Net Cash Flow
34.546.88-15.2826.950.07
Free Cash Flow
-33.42-22.98-23.25-9.91-0.08
Free Cash Flow Margin
-10107.88%-1173.12%-374.36%--
Free Cash Flow Per Share
-0.03-0.06-0.08-0.06-
Cash Income Tax Paid
0-4.85-1.56--
Levered Free Cash Flow
-16.48-12.04-12.08-31.35-
Unlevered Free Cash Flow
-16.1-11.64-12.03-25.51-
Change in Net Working Capital
3.04-4.67-1.03-7.5-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q